Amidst the continued struggle to treat non-small-cell lung cancer, a new study led by Stanford University scientists suggests that a patient's response to immunotherapy may hinge on how immune cells ...

A recently-approved treatment could take a BiTE out of small cell lung cancer by using a person's own body to fight back.

Exposure to wildfire smoke may increase lung cancer patients' risk of dying from their disease, particularly among ...

Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was ...

Scientists say these small health issues might be an early sign of lung cancer - As the NHS offers ‘revolutionary’ blood test ...

Alecensa is used to treat non-small-cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive. Some types of lung cancer can be treated with a drug that works when it is combined ...

In this Review, Simpson et al. summarize the emergent understanding of molecular subtypes of small cell lung cancer (SCLC). They discuss how intratumour heterogeneity and dynamic tumour plasticity ...

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA ... patients with previous or current evidence of interstitial lung disease (ILD) were excluded. An Eastern ...

The frequency of chromosomal abnormalities in AL amyloidosis and their impact on treatment response. This is an ASCO Meeting Abstract from the 2019 ASCO Annual Meeting I. This abstract does not ...